维普期刊资源整合服务平台（V6.5）

31篇 您的检索式：作者名="SOSSI V"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease 显示文摘	Lee CS Samii A Sossi V	2000	Ann Neurol2000，47，：	1
2	Levodopa-in-duced changes in synaptic dopamine levels increase with progression of Parkinson's disease:implications for dyskinesias显示文摘	de la Fuente-Fernandez R Sossi V Huang Z	2004	Brain2004，127，12：	1
3	Bio- chemical variations in the synaptic level of dopamine precede motor fluctuations in Parkinson's disease: PET evidence of increased dopamine turnover 显示文摘	De la Fuente-Fernandez R Lu JQ Sossi V	2001	Annals of neur ology2001，49，3：	1
4	In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease 显示文摘	Lee CS Samii A Sossi V	2000	Ann Neurol2000，47，4：	1
5	Increase in dopamine turnover occurs early in parkinson′s disease:evidence form a new modeling approach to PET 18F-fluorodopa data显示文摘	Sossi V De Fuente-Fernandez R Holden JE	2002	J Cereb Blood Flow Metab2002，22，2：	1
6	Resolution mod- eling in PET imaging; Theory, practice, bene- fits, and pitfalls显示文摘	RAHMIM A QI J SOSSI V	2013	Medical Physics2013，40，06：	1
7	Cerebmspinal fluid amyloid p and tau in I,RRK2 mutation carriers显示文摘	Aasly JO Shi M Sossi V		0，，01：	1
8	Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias 显示文摘	de la Fuente-Fernandez R Sossi V Huang Z	2004	Brain2004，127，12：	1
9	Phosphorylated alpha-synuclein in Parkinson's disease: correlation depends on disease severity显示文摘	Stewart T Sossi V Aasly JO	2015	Acta Neuropathol Commun2015，3，：	1
10	In vivo dopamine transporter imaging in a unilateral 6-hydroxydopamine rat model of Parkinson disease using 11C-methylphenidate PET显示文摘	Sossi V Dinelle K Jivan S	2012	J Nucl Med2012，53，5：	1
11	FISH: further evidence for a role for SMN2 in the disease severity in SMA patients显示文摘	Sossi V Tizziano F	1999	Hum Mol Genet1999，8，：	1
12	Apomorphine-induced changes in synapic dopamine levels: PET evidence for pre-synaptic inhibition显示文摘	Lim AS Sossi V	2001	J Cereb Blood Flow Metab2001，21，：	1
13	Collagen XVIII, containing an endogenous inhibitor of angiogenesis and tumor growth, plays a critical role in the maintenance of retinal struc- ture and in neural tube closure (Knobloch syndrome) 显示文摘	SERTIE AL SOSSI V CAMARGO AA	2000	Hum Mol Genet2000，9，13：	1
14	Biochemical variations in the synaptic level of dopamine precede motor fluctuations in Parkinson's disease: PET evidence of increased dopamine turnover显示文摘	Lu J-Q Sossi V	2001	Ann Neurol2001，49，：	1
15	Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease显示文摘	Ruth TJ Sossi V	2001	Science2001，293，：	1
16	A reversible tracer analysis approach to the study of effective dopamine turnover显示文摘	Doudet DJ Holden JE	2001	J Cereb Blood Flow Metab2001，21，：	1
17	Increase in dopamine turnover occurs early in Parkinson's disease: evidence from a new modeling approach to PET 18F-fluorodopa data显示文摘	de la Fuente-Fernández R Holden JE	2002	J Cereb Blood Flow Metab2002，22，：	1
18	In vivo dopamine transporter imaging in a unilateral 6-hydroxydopamine rat model of Parkinson disease using11C-methylphenidate PET显示文摘	Sossi V Dinelle K Jivan S	2012	J Nucl Med2012，3，：	1
19	Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease 显示文摘	de la Fuente-Femandez R Ruth TJ Sossi V	2001	Science2001，293，5532：	1
20	In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease显示文摘	Lee CS Samii A Sossi V	2000	Ann Neurol2000，47，4：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示